Total Valuation
Innovative Medtech has a market cap or net worth of $98.91K. The enterprise value is $725.35K.
Market Cap$98.91K
Enterprise Value$725.35K
Share Statistics
Innovative Medtech has 70,652,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding70,652,810
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Innovative Medtech’s return on equity (ROE) is -1.20 and return on invested capital (ROIC) is 675.78%.
Return on Equity (ROE)-1.20
Return on Assets (ROA)5.07
Return on Invested Capital (ROIC)675.78%
Return on Capital Employed (ROCE)2.59
Revenue Per Employee0.00
Profits Per Employee1.27M
Employee Count1
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Innovative Medtech is <0.1. Innovative Medtech’s PEG ratio is -0.02.
PE Ratio<0.1
PS Ratio0.00
PB Ratio-2.52
Price to Fair Value-2.52
Price to FCF0.86
Price to Operating Cash Flow0.02
PEG Ratio-0.02
Income Statement
In the last 12 months, Innovative Medtech had revenue of 0.00 and earned 1.27M in profits. Earnings per share was 0.03.
Revenue0.00
Gross Profit0.00
Operating Income-2.73M
Pretax Income1.27M
Net Income1.27M
EBITDA-2.02M
Earnings Per Share (EPS)0.03
Cash Flow
In the last 12 months, operating cash flow was 2.85M and capital expenditures 0.00, giving a free cash flow of 2.85M billion.
Operating Cash Flow2.85M
Free Cash Flow2.85M
Free Cash Flow per Share0.04
Dividends & Yields
Innovative Medtech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.98
52-Week Price Change-70.83%
50-Day Moving Average0.04
200-Day Moving Average0.09
Relative Strength Index (RSI)44.19
Average Volume (3m)15.65K
Important Dates
Innovative Medtech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Innovative Medtech as a current ratio of 0.02, with Debt / Equity ratio of -61.65%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.24
Net Debt to EBITDA-0.32
Interest Coverage Ratio50.25
Taxes
In the past 12 months, Innovative Medtech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Innovative Medtech EV to EBITDA ratio is -1.63, with an EV/FCF ratio of 1.07.
EV to Sales0.00
EV to EBITDA-1.63
EV to Free Cash Flow1.07
EV to Operating Cash Flow1.07
Balance Sheet
Innovative Medtech has $13.62K in cash and marketable securities with $649.21K in debt, giving a net cash position of -$635.59K billion.
Cash & Marketable Securities$13.62K
Total Debt$649.21K
Net Cash-$635.59K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Innovative Medtech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―